2026 Attending Speakers
- Srini Akkaraju, M.D., Ph.D., Founder & Managing General Partner, Samsara BioCapital
- Deborah Baron, Senior Vice President, Worldwide Business Development, Pfizer
- Mira Chaurushiya, Ph.D., Managing Director, Westlake Village BioPartners
- Benjamin Chen, Ph.D., Partner, Panacea Venture
- Bharatt Chowrira, Ph.D., J.D., CEO & Board Member, PureTech
- John Connolly, Ph.D., Interim CEO, 3T Biosciences; Chief Scientific Officer, Parker Institute for Cancer Immunology
- Scott DeWire, Ph.D., Corporate Senior Vice President, Head of Global BD&L, Boehringer Ingelheim
- Guilio Draetta, M.D., Ph.D., Chief Scientific Officer, University of Texas MD Anderson Cancer Center
- Niels Emmerich, Ph.D., Vice President, Search and Evaluation & Global Alliances, AbbVie
- Tony Ho, Chief Scientific Officer & Senior Science Partner, Pivotal Life Sciences
- Rachna Khosla, Senior Vice President, Business Development, Amgen
- Tim Luker, Ph.D., Vice President, Lilly Ventures, West Coast USA Head, Corp BD, Eli Lilly
- Mathai Mammen, M.D., Ph.D., Chairman, CEO & President, Parabilis Medicines
- Grace Han McMahon, Associate Vice President and Head, Pacific Hub, BD&L, Merck
- Carole Neuchterlein, Head, Roche Venture Fund
- Carolyn Ng, Ph.D., Partner, TPG Life Sciences Innovations
- Deborah Palestrant, Ph.D., Partner & Executive Chair, 4:59 Initiative, 5AM Ventures
- Mark Paris, Ph.D., Executive Director, Oncology Search and Evaluation, Daiichi Sankyo
- Sunil Patel, Senior Vice President, Head of Corporate Development and Business Development & Licensing, Merck
- Steven Paul, M.D., Board Chair, FNIH; Venture Partner, Third Rock Ventures
- Robert Plenge, M.D., Ph.D., Executive Vice President, Chief Research Officer, Head of Research, Bristol Myers Squibb
- Jeremy Quirk, VP, BD&L Commercial Portfolio, GSK
- John Reed, M.D., Ph.D., EVP, Pharmaceuticals, Research & Development, Johnson & Johnson Innovative Medicine
- Peter Schultz, Ph.D., President, CEO & Professor of Chemistry, Scripps Research
- Daniel Skovronsky, M.D., Ph.D., CSO & President, Lilly Research Laboratories; President, Immunology, Eli Lilly
- Avi Spier, Ph.D., Executive Director, Search & Evaluation, Novartis
- Nancy Thornberry, Founding CEO & Chair, R&D, Kallyope
- Issei Tsukamoto, Ph.D., SVP, Head of Business Development, Astellas Pharma